Suppresses the cancer painful following methods with the anaesthetic not to be possible to take

The clinical practice proved that prompt, uses the analgesic on time, not only may receive the good analgesic effect, moreover may choose the analgesia intensity low medicine, the use smallest dosage. When if the ache is fierce time uses the analgesic, the patient must suffer the ache suffering. If cannot obtain the analgesia treatment for a long time, because the cancer patient easy to have the ache to cause with the nerve pathological ache related nerve function disorder, displays for over sensitivity to pain and unusual ache and so on difficult the aches. Therefore, when not suitable the ache is fierce uses the analgesic. Can the part alleviation ache then On clinical, carries on the analgesia treatment to the cancer patient ache the goal eliminates the ache, improves cancer patient's quality of life. Let the cancer patient under not the painful condition the sleep, is eases the pain the treatment lowest standard to the cancer patient. The ideal analgesia treatment goal is lets the cancer patient rest, the activity under not the painful condition, the work. Cannot satisfy in the cancer patient ache part alleviates, must pursue the ache to eliminate completely. With pai for ding eases the pain is most effective, is safest Now did not advocate that pai for ding will use in cancer analgesia treatment, WHO pai for ding will not have listed as to cancer ache analgesia treatment medicine. The reason is:①pai for ding the analgesia function intensity is only the morphine 1/10~1/8.②pai for ding the analgesia duration is only the morphine 1/2~2/3.③pai for ding the metabolite to go to the armor pai for ding, to the central nervous system and the kidney virose function, its half-life is 3~18 hours. 4 pai are bad for ding the oral administration biology exploitability, must achieve the analgesic effect oral administration to the incremental dose, this time, goes to the armor pai for ding the quantity rises doubled and re-doubled.⑤Because pai is bad for ding the oral administration biology exploitability, uses the intramuscular injection to give the medicine, but the intramuscular injection itself will cause the ache. In brief, pai for ding is not suitable the patient who uses in the long-term ache. The meconium class medicine only suitably uses for the terminal cancer patient endures the quantity most greatly The clinical practice proved that the meconium class analgesic's amount used has the big individual difference, the minority cancer patient eases the pain the treatment to need the high dose. The pharmacology experiment prompts: The meconium class analgesic not places an upper limit on the effect. So long as the ache intensifies, may increase the meconium class medicine the amount used enhancement analgesia treatment effect. Regarding any specific weight ache patient, regardless of cancer clinical by stages sooner or later, estimate life length, so long as the analgesia treatment need, should use promptly endures the quantity meconium class analgesic most greatly, but cannot only to soon die the terminal cancer patient uses endures the quantity most greatly. The meconium class medicine presents the untoward effect to stop using The clinical practice proved that the meconium class medicine's untoward effect besides the constipation, majority is temporary, is also may endure. Therefore, as soon as sees the untoward effect to appear immediately stops the use meconium class medicine the method not being possible to take. Once the meconium class medicine uses is unable to stop using In medical practice, so long as the cancer patient ache cause of disease is under the control, the ache eliminates, momentarily may stop using the meconium class analgesic. When the morphine everyday use quantity is 30~60mg, will stop the medicine not to have the accident generally suddenly. The decrement will stop the medicine to the long-term massive medication's patient not to have the accident gradually. The decrement stops the medicine to make the law is specifically gradually: In initial two days decrement 25%~50%, every two day of decrements 25%, until the everyday use quantity are when thereafter 30~60mg stops the medicine. In the decrement process, whether there is should observe the cancer patient ache symptom gradually to appear. If has the ache symptom, and grades is bigger than 4, should further slow decrement, avoid stopping the medicine to have the ache symptom and the abstention too quickly breaks the symptom. The meconium class medicine cannot use in the lung cancer patient The practice proved that the meconium class medicine can use in the lung cancer patient ache effectively safely the treatment. Thought that the meconium class medicine cannot use in the lung cancer patient ache treatment the root lying in the meconium class contraceptive to have the side effect which the breath suppresses. In fact, lungs disease causes the scant of breath is circumference venereal diseases changes is the lungs pathological change result, but the meconium class medicine causes the breath suppresses is the side effect result which suppresses to the Respiratory center. The meconium class medicine itself does not aggravate the lungs pathological change. At the same time, the meconium class medicine the side effect which suppresses to the Respiratory center, generally only occurs when the medication excessive or the kidney function not all causes the medicine to store up. The meconium class medicine long-term use can have the energetic dependence In the clinical practice, the long-term use meconium class medicine, adopts the oral administration particularly or passes the skin way to give the medicine, the cancer patient presents the energetic dependence (formerly was called becomes addicted to) the risk extremely micro. Chinese Academy of Medical Sciences harmony Medical college Tumour hospital academician Sun Yan in the be more than 40 years cancer diagnoses in the process, only saw that 4 example patients have the energetic dependence. The average 10 years only then see one time. And, has carried out three steps and ladders pain-relieving therapy since 1990, an example had not seen. Overseas Porter reported that the use meconium class medicine presents the energetic dependent risk to be lower than extremely four (i.e. 4/11882). This explained sufficiently the cancer patient uses the meconium class medicine to cause the energetic dependence to be rare.